Rigel Pharmaceuticals Stock Price on March 11, 2024
| RIGL Stock | USD 26.04 1.00 3.99% |
Below is the normalized historical share price chart for Rigel Pharmaceuticals extending back to November 29, 2000. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Rigel Pharmaceuticals stands at 26.04, as last reported on the 23rd of November, with the highest price reaching 26.18 and the lowest price hitting 25.34 during the day.
If you're considering investing in Rigel Stock, it is important to understand the factors that can impact its price. Rigel Pharmaceuticals is moderately volatile given 3 months investment horizon. Rigel Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.18, which implies the firm had a 0.18% return per unit of risk over the last 3 months. We were able to analyze and collect data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.21% are justified by taking the suggested risk. Use Rigel Pharmaceuticals Coefficient Of Variation of 494.65, semi deviation of 2.44, and Risk Adjusted Performance of 0.1639 to evaluate company specific risk that cannot be diversified away.
At this time, Rigel Pharmaceuticals' Common Stock Total Equity is quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 142.9 M this year, although the value of Common Stock Shares Outstanding will most likely fall to about 16.5 M. . The value of Price To Sales Ratio is estimated to slide to 2.05. The value of Price Earnings Ratio is estimated to slide to -10.56. Rigel Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 29th of November 2000 | 200 Day MA 12.8955 | 50 Day MA 17.1906 | Beta 0.953 |
Rigel |
Sharpe Ratio = 0.1801
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | RIGL | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.73 actual daily | 59 59% of assets are less volatile |
Expected Return
| 1.21 actual daily | 24 76% of assets have higher returns |
Risk-Adjusted Return
| 0.18 actual daily | 14 86% of assets perform better |
Based on monthly moving average Rigel Pharmaceuticals is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Rigel Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 31.6366 | Enterprise Value Ebitda 33.495 | Price Sales 2.9147 | Shares Float 14.7 M | Wall Street Target Price 29.1667 |
Related Headline
Cidara Therapeutics Headline on 11th of March 2024
Disposition of 18931 shares by Shah Preetam of Cidara Therap... by Shah Preetam
Filed transaction by Cidara Therapeutics Officer: Cfo & Cbo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Rigel Pharmaceuticals Valuation on March 11, 2024
It is possible to determine the worth of Rigel Pharmaceuticals on a given historical date. On March 11, 2024 Rigel was worth 15.8 at the beginning of the trading date compared to the closed value of 15.1. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Rigel Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Rigel Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Rigel Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Rigel Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 15.50 | 15.90 | 15.00 | 15.70 | 222,365 | |
03/11/2024 | 15.80 | 16.20 | 15.00 | 15.10 | 134,792 |
| 15.20 | 15.40 | 14.80 | 14.90 | 121,485 |
| Backtest Rigel Pharmaceuticals | | | Rigel Pharmaceuticals History | | | Rigel Pharmaceuticals Valuation | Previous | Next |
Rigel Pharmaceuticals Trading Date Momentum on March 11, 2024
| On March 12 2024 Rigel Pharmaceuticals was traded for 14.90 at the closing time. The top price for the day was 15.40 and the lowest listed price was 14.80 . The trading volume for the day was 121.5 K. The trading history from March 12, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.32% . The trading delta at closing time against the current closing price is 5.30% . |
Rigel Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Rigel Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Rigel Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Rigel financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Rigel Pharmaceuticals Stock history
Rigel Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Rigel is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Rigel Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Rigel Pharmaceuticals stock prices may prove useful in developing a viable investing in Rigel Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 17.4 M | 16.5 M | |
| Net Loss | -67.4 M | -70.7 M |
Rigel Pharmaceuticals Quarterly Net Working Capital |
|
Rigel Pharmaceuticals Stock Technical Analysis
Rigel Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Rigel Pharmaceuticals Period Price Range
Low | November 23, 2024
| High |
0.00 | 0.00 |
Rigel Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Rigel Pharmaceuticals November 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Rigel Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Rigel Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Rigel Pharmaceuticals stock market strength indicators, traders can identify Rigel Pharmaceuticals entry and exit signals to maximize returns
Rigel Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Rigel Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Rigel Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Rigel to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1639 | |||
| Jensen Alpha | 1.07 | |||
| Total Risk Alpha | 0.2906 | |||
| Sortino Ratio | 0.3745 | |||
| Treynor Ratio | 0.5838 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rigel Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more information on how to buy Rigel Stock please use our How to buy in Rigel Stock guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rigel Pharmaceuticals. If investors know Rigel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rigel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.48) | Earnings Share 0.27 | Revenue Per Share 8.979 | Quarterly Revenue Growth 0.966 | Return On Assets 0.0461 |
The market value of Rigel Pharmaceuticals is measured differently than its book value, which is the value of Rigel that is recorded on the company's balance sheet. Investors also form their own opinion of Rigel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Rigel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rigel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Rigel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rigel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rigel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rigel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.